BSX FY 2022 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena

BSXBoston Scientific Corporation

$105B

FY 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$12.7B+6.7% YoY

Gross Profit

$7.7B60.8% margin

Operating Income

$1.8B14.4% margin

Net Income

$698M5.5% margin

EPS (Diluted)

$0.45

Cash Flow

Operating Cash Flow

$1.5B

Free Cash Flow

$914M

Stock-Based Comp.

$220M

Balance Sheet

Total Assets

$32.5B

Total Liabilities

$14.9B

Stockholders' Equity

$17.6B

Cash & Equivalents

$928M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$12.7B	$11.9B	+6.7%
Gross Profit	$7.7B	$7.5B	+3.4%
Operating Income	$1.8B	$1.9B	-5.1%
Net Income	$698M	$1.0B	-32.9%